BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12164218)

  • 21. The structure--antituberculosis activity relationships study in a series of 5-(4-aminophenyl)-4-substituted-2,4-dihydro-3h-1,2,4-triazole-3-thione derivatives. A combined electronic-topological and neural networks approach.
    Kandemirli F; Shvets N; Unsalan S; Küçükgüzel I; Rollas S; Kovalishyn V; Dimoglo A
    Med Chem; 2006 Jul; 2(4):415-22. PubMed ID: 16848755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antitubercular activity of 4-(3-coumarinyl)-3-cyclohexyl-4-thiazolin-2-one benzylidenehydrazones.
    Karali N; Kocabalkanli A; Gürsoy A; Ateş O
    Farmaco; 2002 Jul; 57(7):589-93. PubMed ID: 12164220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antitubercular screening of [(2-chloroquinolin-3-yl)methyl] thiocarbamide derivatives.
    Kumar S; Upmanyu N; Afzal O; Bawa S
    Chem Biol Drug Des; 2014 Nov; 84(5):522-30. PubMed ID: 24750991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity.
    Bedia KK; Elçin O; Seda U; Fatma K; Nathaly S; Sevim R; Dimoglo A
    Eur J Med Chem; 2006 Nov; 41(11):1253-61. PubMed ID: 16919372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antituberculosis agents II. Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole derivatives.
    Foroumadi A; Mirzaei M; Shafiee A
    Farmaco; 2001 Aug; 56(8):621-3. PubMed ID: 11601649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
    Ahsan MJ; Samy JG; Jain CB; Dutt KR; Khalilullah H; Nomani MS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):969-72. PubMed ID: 22197387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of novel [1,2]-diamines with antituberculosis activity.
    Meng Q; Luo H; Chen Y; Wang T; Yao Q
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antituberculosis activity of cycloalkylidenehydrazide and 4-aza-1-thiaspiro[4.5]decan-3-one derivatives of imidazo[2,1-b]thiazole.
    Ulusoy N
    Arzneimittelforschung; 2002; 52(7):565-71. PubMed ID: 12189781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
    Ramprasad J; Nayak N; Dalimba U
    Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of novel pleuromutilin derivatives. Part 1: preliminary studies of antituberculosis activity.
    Dong YJ; Meng ZH; Mi YQ; Zhang C; Cui ZH; Wang P; Xu ZB
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1799-1803. PubMed ID: 25736994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on pyrazine derivatives. XXVI. Synthesis and tuberculostatic activity of N-pyrazinylthiourea].
    Wisterowicz K; Foks H; Janowiec M; Zwolska-Kwiek Z
    Acta Pol Pharm; 1989; 46(2):101-13. PubMed ID: 2517187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.
    Shah NM; Patel MP; Patel RG
    Eur J Med Chem; 2012 Aug; 54():239-47. PubMed ID: 22652224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents.
    Sinha N; Jain S; Tilekar A; Upadhayaya RS; Kishore N; Jana GH; Arora SK
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1573-6. PubMed ID: 15745799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of novel monosubstituted sulfonylurea derivatives as antituberculosis agents.
    Pan L; Jiang Y; Liu Z; Liu XH; Liu Z; Wang G; Li ZM; Wang D
    Eur J Med Chem; 2012 Apr; 50():18-26. PubMed ID: 22326144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1,3,4-thiadiazole derivatives. Synthesis, structure elucidation, and structure-antituberculosis activity relationship investigation.
    Oruç EE; Rollas S; Kandemirli F; Shvets N; Dimoglo AS
    J Med Chem; 2004 Dec; 47(27):6760-7. PubMed ID: 15615525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
    Ali MA; Yar MS; Kumar M; Pandian GS
    Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of new N-substituted-N'-(3,5-di/1,3,5-trimethylpyrazole-4-yl)thiourea/urea derivatives.
    Kaymakçioğlu BK; Rollas S; Körceğez E; Aricioğlu F
    Eur J Pharm Sci; 2005 Sep; 26(1):97-103. PubMed ID: 15990284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents.
    Ren J; Xu J; Zhang G; Xu C; Zhao L; You X; Wang Y; Lu Y; Yu L; Wang J
    Bioorg Med Chem Lett; 2019 Feb; 29(4):539-543. PubMed ID: 30630715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antituberculosis activity of some new pyridazine derivatives. Part II.
    Mantu D; Luca MC; Moldoveanu C; Zbancioc G; Mangalagiu II
    Eur J Med Chem; 2010 Nov; 45(11):5164-8. PubMed ID: 20813433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of antimycobacterial activity of 4-phenyl-1,8-naphthyridine derivatives.
    Ferrarini PL; Manera C; Mori C; Badawneh M; Saccomanni G
    Farmaco; 1998 Dec; 53(12):741-6. PubMed ID: 10230055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.